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Abstract
To address the low success rate of new drug discovery, there has been significant growth of in vitro 
physiological micro-models based on human cells. These may be in the form of cell spheroids, organs-on-a-chip, 
or multi-cellular tissue cultures, and it is expected that the more biomimetic environment they create will be 
more accurate than standard cell culture in drug screening prior to clinical testing. However, commercial use of 
complex co-cultures is still limited. This is due to a lack of validation, low throughput rates, and a lack of 
compatibility with standard assessment techniques. This review paper focusses specifically on the different 
engineering approaches used to create, mature and analyse these micro-models, with the aim of exploring which 
approaches have the potential for high throughput. Active and passive pumping and nozzle based dispensing 
techniques are considered for fluid handling, with transwells, cell patterning, spheroid cultures and microfluidics 
considered for establishing and maintaining co-cultures, together with conventional analysis techniques 
(proteomic and genomic approaches, and immunohistochemistry) and novel sensor systems for downstream 
analysis are considered.  It is concluded that (i) throughput is essential for validation as well as exploitation of 
the models, and (ii) an integrated approach to model re-design for high throughput is key, with the limitations on 
throughput at each stage considered in order to develop a system which can deliver and analyse at high 
throughput rates at all stages of the process.
Keywords:  
High throughput; drug discovery; micro-tissue model; organs-on-a-chip; microfluidics; cell culture; co-culture
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31. Introduction 
Less than 1 in 10 drug candidates which enter clinical trials are approved by the Food and Drug 
Administration (FDA). The high failure rate is attributed to two major causes: (i) nonclinical/clinical 
safety (accounting for >50% failure) and (ii) efficacy (>10%), which current pre-clinical models do 
not accurately predict[1,2]. To address this problem, fabricated multi-cellular in vitro tissue models 
are being explored as a new potential pathway for improved pre-clinical models[3,4]. These models 
can take a number of forms with common approaches utilising cell spheroids[5], lab-on-a-chip (LoC) 
or organ-on-a-chip type systems[6-8], and multi-cellular tissue cultures[9,10]. Multi-cellular models 
are considered to offer environments which are closer in structure and biochemistry to the native 
environment for cells and tissues, and thereby offer the potential to provide a new set of tools for 
understanding disease and the effectiveness of specific therapies[5]. Such models can be based on 
human cells, and so may prove more predictive of response in humans than animal models, reducing 
or replacing the need for animal testing.
The use of fabricated physiological micro-models in the development of therapies or in any clinical 
context has been very limited for a number of reasons[11]: (i) many experiments have low numbers of 
models (or n = 1), with no dilution series, replications, or positive and negative controls; and (ii) there 
is little or no compatibility with standard assessment techniques. As biological processes are to some 
degree stochastic and vary across populations, there is a clear need for biological and technical 
replicates. If it is difficult to scale up, with the difficulty exacerbated by a reliance on assessment 
techniques which are not commonly available, then this make the models slow to develop and validate, 
and low throughput in terms of their ability to provide information on diseases or therapies. The key 
to unlocking the widespread use of physiological micro-models is the ability to run more models 
either quicker or in parallel for higher throughput, as this will facilitate rapid development, validation 
and use of models.
The aim of this review paper is to give an overview of the different engineering approaches used to 
develop and fabricate multi-cellular models, and to explore which approaches have the potential to 
bring higher throughput levels across the process chain.
The main phases of multi-cellular tissue model development are (Figure 1):
(i) establishment of the cultures or co-cultures: positioning of cells and other model constituent 
materials in order to create starting cultures or co-cultures.
(ii) maturation: ongoing culture of cells to allow the starting cultures to mature and provide the 
required functionality.
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4(iii) introduction of compounds: this will commonly involve assessment of a candidate drug, but 
may also involve the introduction of elements designed to stimulate and simulate disease 
within a phenotypically healthy tissue.
(iv) analysis: may be ongoing or terminal, single stage or multi-stage, but quantitative or 
qualitative analysis of the effectiveness of a candidate drug is required. 
Some specific models may have other stages, such as physical damage to simulate an injury, but these 
four stages are relevant to the majority of models. Liquid handling is a key underpinning technology 
for many of the operations in these four stages, and for the “tissue maturation” and “introduction of 
compounds” stages liquid handling is the primary engineering element. In the sections that follow 
liquid handling technologies are first considered, with an overview of active and passive pumping and 
nozzle based dispensing approaches. Techniques for the establishment and maintenance of co-cultures 
are then considered, covering 2D cultures, transwells, cell patterning, spheroid cultures and 
microfluidics. Then, prior to a review of the current state of the art and future outlook, techniques for 
downstream analysis are considered, covering proteomic and genomic approaches, 
immunohistochemistry and also novel sensor systems, often developed specifically for particular 
system designs. 
Figure 1. Flow diagram of key stages involved in physiological micro-model development for drug screening, 
with the main focus areas of this review in blue
2. Liquid handling
The fluid volumes in multi-cellular models are generally small (from nanolitres to millilitres), and so 
microfluidic systems have been widely developed and used in the design of such models. The 
progress of microfluidic technologies for biomedical applications has been the subject of a number of 
review papers in recent years[6-8,12-29]. They include reviews on the general impact of microfluidics 
on biomedical research[7,25], perspectives on building of microfluidic devices[12,14,30], cell 
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5(co-)cultures[18,24,31], the development of specific biomimetic living models[21,22,26,29], 
validation of models in preclinical drug discovery[6,16], high throughput screening[17,20], research 
and commercialization[13], and end-user perspectives[11]. Fluid delivery systems can be seen as 
being either active (normally with an external pump), passive (acting under gravity or surface tension) 
or jetted (using droplets or streams of fluid from pressurised nozzles). Table 1 summarises the 
characteristics of these different modes of fluid delivery, and the sections that follow outline key 
exemplars of the different approaches.
Table 1 Characteristics of different delivery modes for microfluidic cell culture 
Mode Performance High throughput 
possibility
Compatibility 
to existing 
techniques
Ref.
Active 
pumping 
system
Needs external pump and tubing 
system 
Allows continuous flow
Pneumatic multiplexing requires an 
elastic construction material (e.g. 
PDMS) 
Normally based 
on a complex 
design of 
multiplexed 
channels, can be 
automated
Normally  
requires 
expert 
operator
[32-35]
Passive 
pumping 
(including 
gravity, 
surface 
tension or 
osmosis 
driven)
Tubeless 
Needs no electrical power
 ’Open’ system to refill liquid for 
continuous perfusion
Unsuitable for dynamic flow 
Surface-tension driven is limited to 
low volume flows (nL/s to µL/s) 
Gravity-driven 
and surface 
tension-driven 
pumping has been 
demonstrated for 
high throughput 
study
Compatible 
with 
traditional cell 
culture 
equipment, 
automated 
pipetting tools
[36-40]
Nozzle 
dispensing
Needs an open accessible 
microfluidic chip for fluid 
deposition
Needs external source to generate 
fluid stream or droplets
Can be automated 
and suitable for 
high throughput
Needs 
integration of 
perfusion flow 
for long-term 
culture
[41-46]
2.1 Active pumping systems
Traditional external flow pumping systems are the most common form of actuation used in 
microfluidic devices to guarantee a perfusion flow mode[32] (Figure 2A). Syringe pumps in particular 
have been used for non-recirculatory flow and peristaltic roller pumps for recirculatory flow, 
connected with the microfluidic chip via tubing. To minimise the number of pumps required, arrays 
are a common architecture[35,47] (Figure 2B and C). A range of approaches to this technique have 
been described, including new channel architectures to reduce cross-contamination[33,34].      
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6Figure 2. A) A microreactor system composed of four microchips with syringe pumping systems[16]; B) 
reversible sealing of microfluidic arrays onto microwell patterned substrates to fabricate multiphenotype cell 
arrays[47]; C) multilayer pneumatic pump based microfluidic array platform[35]     
2.2 Passive pumping system
Passive pumping methods typically include gravity, capillary force, osmosis pressure, and surface 
hydrophilicity[48]. Structurally simple, passively-driven microfluidic systems have proven to be practical 
and useful for biochemical analyses, cell patterning, and cell sorting systems due to their simple fabrication, 
straightforward operation, portability, and low cost[40]. 
Figure 3  Passive pumping systems of: a) gravity-driven flow[40] and b) its demonstrated example in 96-well 
perfusion microplate for cell culture[36]; c) surface tension-driven flow and d) an array of 192 microfluidic 
channels for surface tension driven flow, each with two access ports positioned according micro-titer plate 
standards[38]; and e) osmosis-driven flow[49]. 
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7Gravity based passive systems typically use liquid mini-reservoirs setting at different heights to achieve 
fluid flow from the higher reservoir to the lower one[37,40,50].  One key advantage of this pumping system 
lies in that the liquid can be re-filled over time to prolong flow and hence it can be considered as an ‘open’ 
system to enable long-term studies. Arrays of horizontally-oriented reservoirs can be engineered to achieve 
a constant flow rate (Figure 3A). The system has been demonstrated in providing flow for multiplexed cell 
culturing and assaying in a standard 96-microwell plate device (Figure 3B)[36].
Surface tension-driven flow can be generated from the difference in pressure inside drops of unequal 
volume (Figure 3C), and has been demonstrated[38] for a high degree of parallelization (96–192 channels 
per array) while retaining basic microfluidic operations including routing, compartmentalization and 
laminar flow (Figure 3D). Such systems are effective and allow refilling of liquid into the inlet for short-
term perfusion; however, it is limited to low volume flow rates (in the range of 30 nL/s to 20 μL/s), making 
it difficult to perform long-term perfusion studies.  
Osmosis-driven flow is induced by a difference in solute concentrations across a membrane that is only 
permeable to the solvent and not the solute (Figure 3e)[39,51]. The flow rate generated is proportional to 
the difference in the osmotic pressure across the permeable membrane as well as the contact area of the 
membrane. The most important characteristic of osmotic pumps is that they can provide very slow, near 
constant flow rates that can last from hours to days, making them suitable for long-term cell cultures. 
However, it does require a more involved setup than gravity-driven flow or surface tension-driven flow.
2.3 Nozzle based dispensing 
Nozzle based dispensing includes traditional pipetting, but the focus here is on automated methods, 
including automated pipetting and bioprinting techniques. Bioprinting approaches have been 
extensively reviewed elsewhere[42,52-55], and the focus here is on the utility of these approaches for fluid 
and cell dispensing. 
2.3.1 Automated pipetting system
The development of automation-compatible and reliable high-throughput technologies is a prerequisite to 
translate micro-tissue development from laboratory assay to industrial applications.  Robotic work stations 
equipped with standard multiple-channel pipette heads are the most automated liquid handling systems 
currently available, and are routinely exploited for automated cell culture. Numerous commercial robotic 
platforms are available[56-62], each having advantages and disadvantages, and in addition there are semi-
automated pipettors[63].  Systems may be further automated with liquid level detection[64]. For pipetting 
systems, the sedimentation of cells and associated variations in dispensed cell number is a challenge.  
Pipettes also have a limitation in terms of dispensing small volumes.  For smaller volume dispensing 
Zhou et al.[46] developed a PDMS liquid pipette chip, and focused acoustics droplet ejection has been 
successfully employed to inject droplets of nanoliter and picoliter volumes from a reagent source plate 
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8to an assay plate without contact, eliminating the wash step[44,65]. More recently, a novel nanoliter 
centrifugal liquid dispenser has been developed for introducing nanoliter reagents into microwell 
arrays[45]. Low cost, home-made robotic workstations, have also been developed for automated fluid 
delivery system for high-throughput experiments, but subject to potential cross-contaminations 
between sequential samples[66]. 
2.3.2 Inkjet and micro-valve systems
Inkjet systems enables accurate deposition of single picoliter drop volumes[67] of a large range of materials, 
materials in solution or cells in media, under digital control at defined spots on the surface of a wide variety 
of substrates. Inkjet printing is best suited to low viscosity materials[68]. For cell printing, each inkjet drop 
will typically contain a few cells, with much research effort directed towards a single cell per drop[69], and 
the major issue which has to be overcome is cell agglomeration leading to nozzle blocking[70]. Single 
micro-valves can be used to deposit larger droplets (pL to nL sized) than inkjet, with similar restrictions on 
viscosity[71]. The microvalve system shows advantages in high throughput printing with higher rates of cell 
density possible[72,73].  A single inkjet or microvalve is essentially a liquid dispensing system, but 
post-print crosslinking can allow for the creation of more viscous materials, with the crosslinking 
typically enabled through UV cure[74] or a reactive substrate[75].
2.3.3 Multiple-jet systems 
To enable more complex reactions with inkjets or micro-valves some twin jet systems have been 
developed. On-substrate reactions with two adjacent microvalves has been used[76,77], and multiple 
cell types can be delivered to surfaces using multiple jets[78]. A twin piezo system can be used to 
create arrays of gel droplets[79], and impinging droplets from two micro-valves have been shown to 
offer the ability to deposit gels with very high cell densities[72]. Gels can offer a more physiological 
environment for cells, as a hydrated environment, but with mechanical properties replicating those of 
soft tissues[80]. Micro-valve jetting systems[81] can also create encapsulated spheroids through 
jetting droplets into a stream of crosslinking solution[81]. 
2.3.4 Extrusion of cell filled gels
The most commonly exploited bioprinting approach is the extrusion of cell filled gels from a syringe-
like container[53]. This can be limited in terms of cell density and deposition speed, and ink 
formulation is key to achieving good quality output[54]. One approach to overcome these limitations 
is the use of a mixing cartridge which delays mixing the gel components until the point immediately 
before extrusion[82,83].
3. Establishing and Maintaining Co-cultures  
Table 2 summarises the main methods used for establishment of both direct contact co-cultures and 
physically separated co-cultures, and the sections that follow outline key exemplars of the different methods.  
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Table 2. Methods used for co-culture establishment 
Methods Description Co-culture Advantages Disadvantages Ref.
Monolayer 2D 
co-culture
A conventional approach 
mixing two or more different 
cell types in a culture
Direct 
contact
Simple and straightforward
Low-cost and high speed of 
testing
Limited relationship to in vivo environment and 
response
[84-86]
Transwell inserts 
system/membrane 
filter system 
Polyester or polycarbonate 
membrane with fixed pore sizes 
to segregate one culture on the 
membrane from a second 
culture below the membrane
Direct 
or 
indirect
Large volume
Compatible with standard 
techniques/assays and cell culture 
robots
Limited to two compartmentalized cultures 
(except the tri-cultivation case) 
Can have long diffusion times due to the large 
distance from Transwell membrane to the base of 
the well
[5, 87-95]
Cell-patterning Using a cell-manipulation 
platform to pattern cultured 
cells form multiple cell types 
with desired arrangement 
according to the cell adhesion to 
micropatterned surfaces 
Direct 
or 
indirect
Can  position multiple cell types
Cell deposition can be non-
invasive, contactless
Precise control of spatial 
configuration
Relies on external conditions (e.g. substrate 
modification, etc.)
Potential effect on culture from artificially 
introduced substrate heterogeneity
Not always suitable for large-scale process
[96-103]
Cell Spheroid Spheroids, spherical aggregate 
of cells in static or stirred 
suspension culture, are 
amenable to the co-culture of 
different cell types, in particular 
tumour cells and normal cells.
Direct 
contact
Better mimic the heterologous 
cellular environment in a solid 
tumour or at sites of metastasis
Mostly used for co-culture of 
physical contact cells 
wide range of preparation 
strategies (e.g. hang-drop, etc.)  
available for the co-culture
Size and uniformity can be difficult to control  
Limited number of human tumour cell lines have 
capacity to grow in spheroid cultures
[5, 92-95]
Microfluidic 
platforms
Bespoke design for co-culture, 
with different compartments 
separated by either fluid channel 
or membranes
Direct 
or 
indirect 
Precise spatial and temporal 
control
Design flexibility
Complexity may limit scalability 
Not always compatible with standard assessment 
techniques
[8, 13, 15, 
16, 26, 29, 
104-108]
3D scaffold Cells are seeded on or migrating 
to cell-interactive solid supports 
as extracellular matrix substitute 
(e.g. collagen hydrogels) 
Direct 
or 
indirect 
More effectively replicating cell 
interactions with extracellular 
matrix
Needs pre-mixing of cell types in a suspension 
before seeding on scaffolds or cross-linking into 
scaffolds, or sequential seeding
Geometric variations and tolerances in scaffold 
manufacture a potential additional source of 
variability 
[109-112]
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3.1 2D Co-Cultures and Transwell Insert Systems
2D monolayers with mixed cultures of different cells in well plates/flasks are the most simple and 
straightforward way to create a direct contact co-culture, but they lack interplay with stroma and the 
3D architecture of a tissue. Monolayer co-cultures do however introduce the issues related to co-
cultures, namely that separating out the cell populations for analysis is difficult, and that most cell 
types will have optimised media, which may not suit the other cell type in a co-culture. Used in their 
simplest form, Transwells allow two cell types to be co-cultured without being in direct contact, 
sometimes in their own media (depending on the transwell design), but whilst allowing exchange of 
supernatant through a porous membrane[87-89,91] (Figure 4). Complex cultures in either upper or 
lower chambers may be used to generate more complex transwell based models[89,90,113-115].  
Figure 4  schematic representation of indirect contact(i), direct contact(ii)[88] and tri-cultivation (iii)[89] co-
cultures using transwell system
3.2 Cell Patterning
Micro-patterned cell co-cultures are generally based on modifications to substrates to produce specific 
patterns that show different affinities to cells. The modifications may be chemical or structural, in order to 
change surface chemistry[116]  or topology[117,118],[119-121], as these allow some control of  cell 
sensing and purpose-specific cell-regulating cues development[122]. Approaches to developing 
structured patterns include etching based on microfabrication techniques including plasma[123], UV-
assisted capillary moulding[120], lithography methods (soft-, photo-, colloidal-, etc.)[121,124], and so 
on[122,125]. Another important approach is surface coating with cell adhesive biomolecules including, for 
example, collagen[126], laminin, fibronectin[127], antibodies[128], bovine serum albumin (BSA)[129], 
gelatin[116], peptide and aptamer ligands[121], and glutaraldehyde[130,131,132]. Surface silanization 
is often combined with photolithography to provide selective micropatterning for selective attachment 
of cells to targeted area[133]. In addition the application of both stencils[99,100],[101,102] and 
meshes[97] has been used to give micropatterns, with the former approach having been developed 
further as “cell sheet technology”[98].
3.3 Cell Spheroids
Multicellular spheroids are more similar in structural and functional terms to tissue than 2D 
monolayer co-cultures, and have been of particular interest for modelling metastasis and solid tumour 
growth. A series of techniques have been developed over the years to produce spheroid co-cultures 
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(Figure 5), including hanging drop, rotary cultures (e.g. spinner flasks), micropatterned plate (e.g. 
concave microwell[134,135]), nonadhesive culture wares, and scaffold-based methods, each with 
particular advantages and disadvantages[93]. Spheroids can be integrated with fluidic networks to 
establish them within perfusable circuits for nutrient supply, substance dosage and inter-organ 
metabolic communication between parallel formed models [136]. In particular, cultured in a concave 
microwell based on standard plasticwares as fabricated through rapid prototyping methods, the 
spheroids are easy to integrate with a high-throughput workflow for drug screening[134,135]. 
Figure 5. A) 384 hanging drop array plate and a cartoon of the spheroid formation process. The size of the 
spheroid is controlled by the number of cells seeded into each hanging drop[137]; B) Schematic showing a two-
layer PDMS-based microfluidic device for the generation of uniformly-sized embryoid bodies. The cells are 
firstly introduced into the upper channel to fully cover the membrane before spontaneously aggregating to form 
embryoid bodies as the membrane are resistant to cell adhesion.[138] C) scaffold-based method for spheroid 
formation[93].
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Closely placed tissue spheroids undergo tissue fusion — a process that can allow larger organoids to 
be generated[139].  The limitations of spheroid culture are that not all cell types (including many 
tumour cell lines) have the capacity to grow in spheroid cultures[95], it can be difficult to form and 
reliably maintain spheroids of uniform size, or to form spheroids with small numbers of cells, and, as 
for monolayer co-cultures, analysis of individual cell types can be difficult[140]. 
3.4 Microfluidic Platforms
3.4.1 Device material selection & functionalization 
So far, Polydimethylsiloxane (PDMS) is still the most commonly used material for microfluidic 
designs, primarily because of the ease of moulding and low cost.  However, PDMS is increasingly 
criticised for leaching of un-crosslinked oligomers that can contaminate culture medium and bind to 
cell membranes[141], and also the negative effect of PDMS on cell metabolism and proliferation in 
long-term culture[24]. PDMS structures are also difficult to mass produce. As such, alternative 
materials ranging from glass, polystyrene (PS), polycarbonate (PC), acrylic, polymethylmethacrylate 
(PMMA), cyclic olefin polymer, polyaryleterketone (PAEK), polylactic acid (PLA) and other 
polymers have emerged as chip materials in standard and customised microfluidic cell culture 
equipment offered by a range of commercial providers[18,142,143]. In particular, PS, being the most 
common macroscale cell culture material, is popular, readily available in high volumes, and can be 
processed for cell culture using a range of methods (e.g. micromoulding [144], hot embossing[145] 
and ‘Shrinky-Dinks’[146]). 
The majority of microfluidic device materials do not have optimal surface properties for cell adhesion 
and proliferation, and require surface functionalisation. Both flow rate and shear stress of the laminar 
flow in microfluidic devices influence the efficiency of cell adhesion and detachment. The application 
of shear stress can deform cells and enlarge the contact area between cells and microchannel surfaces, 
hence enhancing the cell adhesion to the surface[130,147-149], while an increased shear stress 
reduces cell adhesion rates. Surface treatments are also required to inhibit unwanted cellular 
attachment in the flow channels or the non-specific protein adsorption from the culture medium[18]. 
PEO (polyethyleneoxide) based coatings[123,150,151] are a common approach. For cell detachment 
from substrate surfaces, trypsin and dispase are available to remove cells[152], and the process can be 
influenced by wall shear stresses[130,153]. 
3.4.2 Throughput enhancement with well-format-based design 
Organ-on-a-chip systems are increasingly more application focussed, and conventional well plate formats 
that are compatible with standard robotic and fluorescent plate readers are increasingly being used as a 
template for platform design. The microfluidic setup is either integrated to existing industry-standard well 
format or devised into a multi-well plate analogue, for high throughput assays and for standard lab 
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equipment compatibility, and a variety of these are summarised in Table 3, with exemplars in Figures 6 and 
7.  
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 Table 3 Representative microfluidic platforms interfaced with well plate format  
Platform Well Format Remarks Organ models Ref.
Standard-well-format-based
Vulto group: organoplate (MIMETAS) 384-well plate with 96 
microchambers
PDMS-free;
The most compact and throughput organ-on-a-
chip system on the market
Neurons, hepatocytes, endothelial 
cells, kidney proximal tubular cells, 
cancer cells, etc.
[108, 
154, 
155]
Vasculerized micro-organ (4Design 
Biosciences)
96-well plate with 12 tissue 
units
PDMS layer is attached to 96-well plate by a 
chemical gluing method;
Generation of interstitial flow for vascular 
angiogenesis
 Endothelial cells, Micro 
vasculature, tumor cells 
[156-
158]
Angiochip2.0: InVADE 96-well plate for multi-organs 
with up to 20 tissues
Polystyrene-based multi-well plate;
Allows microvascular perfusion across multi-
organ tissues
Supporting various parenchymal 
tissues such as tumor, liver, cardiac 
tissues, etc. 
[159, 
160]
DAX-1,AIM BIOTECH Compliance with the 
SBS/ANSI 384-well plate 
standard with AIM chips fitted 
Non-PDMS plastic with gas-permeability and 
excellent light transmittance 
Compatible with all polymerisable gels, 
controllable interstitial flow 
Direct culture of vasculogenesis 
and angiogenesis, co-culture with 
tumor cells
[161, 
162]
Well-format-analogue
µOrgano Well plate allows more than 
100 individual units
PDMS-based plate and connectors
A platform of multi-organ-chips 
Supporting tissues such as heart, 
liver and fat tissues, etc.
[163, 
164]
PREDICT96(Draper) 96-well PDMS-free
A portable and reconfigurable multi-organ
Precise flow control based on electromagnetic 
actuators
Allows for real-time data collection by 
integrated microscale sensors
Five organs: ovary, fallopian tube, 
uterus, cervix and liver with a 
sustained circulating flow between 
all tissues
[165, 
166]
LiverChip®: Microfluidic multi-well 
plate (BioCN)
12-well & 36-well Polysulfone-made top plate (contacts cells and 
media)
Enables extended cell culture ( >1month) 
liver [167, 
168]
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Figure 6 (A) OrganoPlate® based on a 384-well plate consists of arrays of 96 chip-based microchambers with 
each microchamber being a three-lane bioreactor glued to the bottom of 4 consecutive wells[108]. The adjacent 
lanes are separated by a phaseguide technique to build a stratified 3-D cell culture system. Some optical assays 
are available from an observation window. (B) A vascularized micro-organ (VMO) platform chip based on 96-
well plate[157]: 6 tissue units arranged on half of the well plate, with each occupying 6 horizontal wells. One 
tissue unit consists of 3 tissue chambers (T1-T3) connected to 2 adjacent microfluidic channels, 2 gel loading 
ports (L1-L2), 2 medium ports (M1 and M2), and 1 pressure regulator unit(PR). (C) Illustration of an integrated 
vasculature for assessing dynamic events (InVADE) based on a scaffold integrated 96-well plate[159]. Images 
from left to right and top to down are: Schematic overview of cover, wells and base; SEM (Scale bar 1 mm) of 
the tissue chamber for the liver model with a scaffold suspended across and of the tissue chamber for the heart 
or tumor models with a scaffold, attached with four cantilevers, suspended across the tube; magnified SEM 
(Scale bar 200 μm) showing the main channel and the microholes on the side channel walls of the scaffold; 
illustration of the scaffold seeded with endothelial cells and parenchymal cells showing the spatial configuration 
of the co-culture environment.
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Figure 7 (A) Photographs of LiverChip® device based on a perfused multiwell with an array of 12 bioreactors. 
The left includes inserted photographs of a bioreactor and a scaffold (scale bar on channels with cells image 300 
mm). The right shows the built-in connectors and pneumatic lines distributing positive and negative air pressure 
to individual valves and pump chambers in a partially docked perfused multiwell[167]. (B) Underlying concept 
of the μOrgano system: Schematics depicting the basic μOrgano components: the master-organ-chip and 
exemplary plug & play connectors. Conceptual idea of the usage principle of the μOrgano system for the 
connection of two microphysiological systems (MPSs) in series via a simple linear channel connector with a 
close-up of the connected system highlighting the resulting media flow[163]. 
3.4.3 Enhanced Organ-on-a-Chip Approaches
The microvascular system uses microvessels and capillaries to transport oxygen, blood and nutrients 
throughout the entire body. This system enables tissue functionality, supports diverse biological 
phenomena and contributes to the close interactions among the organs[29].  Lee et al.[170] have 
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reviewed the latest advances achieved with regard to the microfluidic-based vascularized 
microphysiological systems (MPS), which can address lumen structure formation[171], the role of 
interstitial flow in regulating the angiogenic response[172], blood-brain barrier models[173], and 
tumour spheroid development[174,175]. 
Depending on the application, physical cues such as mechanical stimulation, electrical stimulation and 
biochemical stimulation can be useful in improving maturation of the in-vitro micro-tissue[176]. One 
example is a lung-on-a-chip model[177], where cyclic stretch was introduced to mimic the effects of 
breathing on the alveolar epithelium and endothelium, and there are also examples applied to 
electrical[178-180] and mechanical[181-183] stimulation of in-vitro cardiac tissue. External 
stimulations have also been investigated for the regulation of nerve[184], skeletal muscle[185] and 
liver[186] tissues.
Body-on-a-chip or human-on-a-chip models, integrating multiple organs may be useful in the 
modelling of systematic interactions between various tissues and organs[187-191]. Organoids for liver, 
cardiac and endothelial modules have been integrated in microfluidic devices under common media, 
showing sufficient viability[187,189,190] (Figure 8A). Lee et al.[192] have recently combined a 
pumpless multi-organ-on-a-chip (operated with gravity-induced flow) to evaluate the metabolism-
dependent anticancer activity of a flavonoid, luteolin. As previously noted in Table 3, multi-organ 
models based on a standard 96-well plate have been developed[159]. In this work, a built-in 
microfabricated vascular bioscaffold was developed to define vascular space and support self-
assembly of various parenchymal mini-tissues including a metabolically active liver, a free-
contracting cardiac muscle, and a metastatic solid tumour. Based on the platform, the complete cancer 
invasion-metastasis cascade has been demonstrated across multiple organs through the common 
vasculature (Figure 8B). In general, scaling of multiple organ models is considered a complex 
task[193-195].  
4. Analysis  
Analysis of tissue models can be undertaken in a number of ways, with the key logistical 
consideration being that the rate at which models can be assessed needs to match the rate at which 
they are produced. Conventional proteomic and genomic bioassays may be used for samples of 
culture media or cultured tissue, and have their advantages (see Table 4) but for the purposes of this 
paper we will predominantly focus on reviewing engineering approaches which aim to allow for in-
situ assessment of tissue model behaviour. These include adaptations of conventional techniques for 
in-situ analysis, and the development of new sensor systems. These are considered in turn below.
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Figure 8. Multi-organs on a chip. (A) (i) A depiction of a liver, cardiac, and vascular organoid-containing body-
on-a-chip platform. Individual organ chips are connected through a central breadboard, with integrated flow 
control and imaging , and (ii) photograph of a three organoid system[187]. (B) A schematic diagram of InVADE 
platform. Multiple organ models utilise a common geometry and 96 well platform. Interconnected wells allow 
for the organ models to be arranged in a linear sequence[159].
Table 4 Comparisons between Conventional and In-situ Bioassays 
Method Advantages Disadvantages Available bioassays
Conventional Readily 
available and 
standardized;
Cell culture volumes 
are typically quite 
small (nL to mL 
scale), rendering the 
signal-to-noise ratio 
low in comparison to 
classical cell culture 
techniques
 Immunohistochemistry
Enzyme-linked immonabsorbent assays 
(ELISA)
Luminescence liquid/gas chromatography-
mass spectrometry (LC/GC-MS)
RNA expression and colorimetric assays
In-situ High signal–to-
noise ratio as 
small volume is 
required
Assays need to be 
tailored to the 
microfluidic 
environment
 Immunohistochemistry
Permeability
Trans epithelial electric resistance (TEER)
Migration assays
Angiogenesis and other optical readouts 
(e.g. calcium imaging, colorimetric and 
luminescence)
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4.1 Adaption of Conventional Techniques for Micro-Tissues
4.1.1 Immunohistochemistry and proteomic assays
Immunohistochemical staining is the dominant in-situ analysis technique[11]. This is due to its relative 
simplicity, involving the sequential introduction and removal of liquid reagents, and the fact that it provides 
information on both the presence and location of target molecules. Once stained and imaged, quantification 
is also possible based on image analysis software[196].
The principle proteomic approaches of relevance are gel electrophoresis, ELISA and preparation for 
mass spectroscopy. Further depth on some aspects of proteomics on-a-chip can be found in previous 
review papers [197,198].
Gel electrophoresis on-a-chip systems have been developed based on having a moving blotting 
membrane interfaced to a microchip[199], or arranging different anti-bodies in a series of parallel 
micro-fluidic channels[200], or through a microchip with electronic control and a novel gel 
formulation[201] (Figure 9A). 
ELISA-on-a-chip systems must address the immune complex reaction and signal readout. The 
immune complex reaction antibodies can be present in solution[202,203], attached to the surfaces of 
the microfluidic channels[204], or linked to beads for increased surface area (magnetic[205-207] or 
otherwise[208-211]; Figure 9B).  Magnetic beads can also be used as both the functionalized surface 
and as a method of mixing fluids within channels[205,206]. For signal readout, 
optical/fluorescent[212,213], electrochemical (EC)[214,215] and mechanical[216] methods have been 
integrated into microfluidic platforms. EC immunosensors are usually based on immobilization of 
antibodies on the surface of EC electrode for antigen detection, which gives a system that is 
essentially single use[217,218], but disposable microbeads have been used to immobilize antigen-
recognition molecules[215], which allows for a continual quantification of biomarkers. Recent work 
has demonstrated that multiplexed ELISA immunoassays can be carried out on-chip[107,208]. 
Mass spectroscopy is a key proteomic technique, and microfluidic reactors functionalized with 
pepsin-agarose have been designed to enable rapid digestion of proteins prior to on-line analysis by 
electrospray ionization mass spectrometry (ESI-MS)[219]. Microfluidic proteomic reactors have also 
been designed to allow for parallel analysis of multiple protein samples with capture, reduction, 
alkylation and digestion simultaneously completed on the same device[220], and enzymatic reactors 
with trypsin and pepsin immobilized inside a microchip have been recently used to accelerate protein 
digestion and proteolysis[221-223]. 
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Figure 9. (A)  Comparative schematics between conventional Western blotting (i) and µWestern blotting (ii) 
assays, and a scalable electrode array accommodating 48 blots per chip to interface with a standard microscope 
slide-sized chips (iii)[201]; (B) Schematic diagram and pictures of a point-of-care ELISA-like assay[224]. (i) A 
preloaded sequence of multiple reagents passively delivered over a series of four detection zones, each 
characterized by dense meanders coated with capture proteins, before exiting the chip to a disposable syringe 
used to generate a vacuum for fluid actuation. (ii) Illustration of biochemical reactions in detection zones at 
different immunoassay steps. The reduction of silver ions on gold nanoparticle–conjugated antibodies yields 
signals that can be read with low-cost optics (for quantification) or examined by eye. (iii) Picture of cassette 
with a tube filled with sequence of reagent plugs (here, colored dye) and syringe for generating vacuum. No 
other peripherals are needed to run the mChip. Silver signals can be read by eye (similar to rapid tests), or with 
the use of a sensitive absorbance reader, which can aid objective determination of positive and negative results 
based on optical density.
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 4.1.2 Genomic assays 
The two main techniques of interest for genetic analysis are polymerase chain reaction (PCR) for 
DNA amplification (which has been recently reviewed[225]) and fluorescent in-situ hybridization 
(FISH). 
To take a fluid through the PCR thermal cycles, serpentine channel designs with three distinct built-in 
temperature zones are a common design, with the fluid repeatedly passing through the temperature 
zones[226], although radial designs are also possible[227,228]. Figure 10A-i shows a recent 
microfluidic PCR device made of polyimide with three resistive copper heaters integrated beneath the 
microchannel[229]. Stationary systems rely on temperature profile design to facilitate fast 
heating/cooling or accurate temperature control. Various active heating approaches have been 
employed for PCR thermal cycling, including light (tungsten lamp[230], LED[231] or modulated 
laser[232]), acoustic waves[233], Peltier elements[234], micro machined Joule heat-based systems 
such as thin film heaters[235] and heat exchangers[236]. For active cooling fans[237], flowing media 
(e.g. water or propylene glycol/water)[238] and heat exchangers are popular.  Figure 10A-ii shows a 
recent example of a stationary µPCR system using an ultrafast photothermal light-to-heat conversion 
for PCR thermal cycling[231]. It is worth noting that the electrophoresis on-a-chip techniques 
described for proteomics can potentially also be integrated with DNA amplification[239]. 
Cao et al[240] review advances in digital PCR (dPCR) and note that this technique is well suited to 
microfluidic approaches, and in addition, loop-mediated isothermal amplification (LAMP) PCR[241] 
has been shown to be an approach which lends itself to miniaturization[242,243].  
Microfluidic approaches to FISH are emerging, with the need for flow and temperature control over 
extended time periods making these quite complicated devices[244], but FISH platforms have been 
demonstrated for various sample types, including cells[245-248] and tissue sections[249-251]. Flow is 
of particular value in increasing the hybridization efficiency[251] (Figure 10B).
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Figure 10. (A)  Example figures of microfluidic PCR (i-a) Photograph of a fabricated PCR device. The three 
temperature zones defined by the three copper (Cu) microheaters beneath the meandering microchannel, are 
shown. In the inset, a part of the device is shown in magnification, where details of the microchannel and the Cu 
microheaters are visible at the top and bottom side, respectively. (i-b) Experimental setup for testing the PCR 
chip for DNA amplification.[229] (ii) Ultrafast photonic PCR. (ii-a) Schematic of the plasmonic photothermal 
light-to-heat conversion and subsequent heating of the surrounding solution (here, the PCR mixture) through 
ultrafast photon–electron–phonon couplings. When light is turned off, fast cooling of the heated solution can be 
achieved by the heat dissipation through the thin Au film. (ii-b) Schematics of the ultrafast photonic PCR using 
a thin gold (Au) film as a light-to-heat converter and excitation light from the LEDs. Thermal cycling, 
consisting of two or three discrete temperatures for denaturation, annealing and extension, is required for nucleic 
acid amplification through the PCR. For multiple PCR reactions, each LED could be modulated separately so 
that there are unique annealing temperatures for each primer design.[231] (B) (i) Principle of FISH assay.[252] 
(ii-iii) FISH microfluidic platform for detection of HER2 amplification in cancer cells. (ii-a) Schematic diagram 
of the FISH chip for use with clinical tissue samples. (ii-b) A photograph of the microfluidic chip (2.2 cm x5.7 
cm). The blue colour indicated the liquid layer, and the red colour indicated the air layer. Ø: diameter. (iii-a) 
Results of fluorescence pictures compared between positive and negative cases of HER2 over-expression[244]. 
4.2 Novel Sensor systems
The most common in-situ sensor systems are optical sensors, coupled with fluorescence- and 
absorbance-based measurement systems[253], which have been used to obtain structural and 
functional information with regard to various cellular activities such as cell viability, cytotoxicity and 
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cell apoptosis[254-256]. There is also growing interest in a label-free sensing of bio-molecular 
interactions based on surface plasmon resonance (SPR) as a result of collective charge density 
oscillation on a metallic surface[257,258]. This allows monitoring of morphological changes in 
cultured cells, detection of the distance between cells and metallic substrates in cell culture chambers, 
and quantitative analysis of mass/area cell changes using phase contrast and fluorescence images[259]. 
The sensitivity can be enhanced with localized SPR (LSPR), which extends the optical measurement 
to spatiotemporal, quantitative and real-time mapping of proteins secreted from cells and the cellular 
function immunoanalysis[260,261]. (Figure 11A)
Figure 11. (A)  Principle of nanoplasmonic sensing platform-integrated microfluidic cell culture devices[260]. 
(B) Scheme of a microfluidics-based setup for oxygen and glucose measurements. Tissue-embedded oxygen 
sensors in a bioreactor mounted on a microscope are excited via OPAL unit controlled LED signal modulation, 
and the signal are analysed through a photomultiplier readout. Bioreactor outflow was connected to a 
microfluidic switchboard containing a series of pressure-controlled micromechanical valves that introduced 
samples into a unit (controlled by a potentiostat, PSTAT) containing electrochemical sensors for glucose and 
lactate. Optical, pressure, and electronic sensors were connected to a single microprocessor that synchronized 
the signal. Right top: Jablonski diagram describing the generation of phosphorescence with Ru-CPOx beads 
under the influence of oxygen. The quenching of the phosphorescence by triplet oxygen leads to a decrease in 
signal intensity and phosphorescence decay time (T1). Right bottom: H2O2 is created in equivalent amounts of 
the analyte as an intermediate product by the activity of glucose oxidase (GOx) or lactate oxidase (LOx)[105]. 
(C) Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid 
behaviour[1]. (D) Cardiac-on-a-chip model with functional readout of cardiac contractility[262].  
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Electrochemical approaches can provide information on glucose, lactate, oxygen and pH, and 
temperature[105]. Typically, an amperometric sensor is designed in a two/three electrode 
configuration to measure the current generated in the system that can be proportionally related to the 
concentration of the analyte (e.g. glucose or lactate). Such amperometric sensors have been widely 
integrated into microfluidic platforms, sometimes functionalized with oxidase enzymes for sensitivity 
enhancement, for glucose and lactate monitoring and quantification[105,263] (Figure 11B). They can 
be made as a separate sensor plate to be plugged in microfluidic chips[263]. Voltage and conductivity 
measurements have also been utilized for sensor designs[264], and systems have been developed to 
sense cell secreted biomarkers[215,265]. In contrast to optical measurement, the electrochemical 
sensors require frequent recalibration and demonstrate significant decay over time, which can 
complicate the microfluidic design with an additional setup to wash and recalibrate the sensors[105]. 
A further approach for oxygen sensing is based on a reversible quenching of luminescence or 
phosphorescence of ruthenium-based dye in the presence of oxygen[266]. In particular, luminophore 
Ru (Ph2phen3)Cl2  (Ruth) dye has been used for fluorescent excitation[267,268] and ruthenium–
phenanthroline-based dye (CPOx-50-RuP) has been used for phosphorescence[105]. To be integrated 
into a cell culture system for real-time monitoring, the dyes are often coated on a bead or micro-
particle. The use of particles can yield a higher signal-to-noise ratio for a better readout as a higher 
dye concentration can be accommodated without inducing self-quenching effects[269], and micro-size 
oxygen sensing particles have recently become commercially available[270,271]. Opto-chemical 
process have been utilized to design pH sensors for on-line pH monitoring, mostly based on the 
optical adsorption of dyes such as phenol red with an optical fibre light source[272].  
Multi-sensor systems to be integrated into organs-on-chip platforms for automated and continual in-
situ monitoring of biophysical and biochemical parameters[1,273], with a fluidics-routing 
breadboard/switchboard often introduced to connect the sensors and the organs in a reasonable 
sequence to realize the operation in a continual, dynamic and automated manner (Figure 11C)[1]. In 
addition, biosensors can be assembled with cultured micro-tissues to provide online monitoring of the 
biomechanics and maturation status of the tissue[262] (Figure 11D). These devices require a complex 
3D architecture, with 3D printing technologies commonly used to create these[274-276].  
5. Current Position and Outlook 
A wide range of technologies have been explored to create, maintain and analyse physiological micro-
models, driven by the lack of overall functional prediction obtained from existing in vitro approaches. 
However, there is still little clinical uptake and a lack of clinical validation for models. It is perhaps 
worth re-iterating that “all models are wrong, but some are useful”[277], and that validation is key to 
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understanding the usefulness of any model. High throughput and validation are to some extent 
coupled problems in this context: without high throughput approaches the multiple models required to 
give the replicates, controls and serial dilutions required for validation cannot be created, and so 
throughput remains important to unlocking the wide-scale use of physiological micro-models.
The primary fluid handling challenges relate to (i) repeatably dispensing low volumes of cells in 
media, and (ii) dispensing high viscosity materials with high cell densities. Both of these challenges 
can be complicated by the need to deposit different materials in a spatially gradient manner. Meeting 
the different dispensing requirements of the different constituents of models will likely require a range 
of dispensing techniques to be deployed in parallel.
In moving towards high throughput models the adoption of standard well-plate formats, compatible 
with existing automated and semi-automated cell culture and biological assessment techniques, can be 
considered the “second wave” of tissue-on-a-chip techniques, in contrast to the “first wave” of more 
complex experimental set-ups with low numbers of replicates. 
The need for high throughput analysis and characterisation has led to a number of innovative on-chip 
characterisation techniques. Most of the approaches reported in the literature rely on a single 
analytical technique for technological validation, whereas in practice the use of a cascade of 
techniques, for example to filter down a large number of replicates to give a sub-set for further 
investigation may be a more useful approach. Recent work embedding multi-sensor systems on-chip 
offer an alternative approach to scaling assessment, allowing read-outs to be combined to more 
effectively filter down results to those of interest.
In conclusion we can say that the drivers for more predictive in vitro modelling remain clear, that 
models based on complex co-cultures are continuing to emerge with an increasing focus on usability 
and integration with commonly available equipment. Systematic approaches to translating models 
from low to high throughput are required, together with the specification and validation of models 
being better understood, and with further development, integration and alignment of model creation, 
maturation and analysis. 
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